| 查看: 1962 | 回复: 21 | ||||
| 当前主题已经存档。 | ||||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | ||||
[交流]
【求助】制药企业的Q1a到Q10都代表什么？
|
||||
|
最近刚去一家制药企业，不知道Q1a到Q10都代表什么？ 有虫子知道的吗？谢谢 |
回复此楼» 收录本帖的淘帖专辑推荐
 我的，就是大家的 |
» 猜你喜欢
氨基酸的酰化反应，求大佬解答
已经有0人回复
-
26年申博——已发SCI6篇
已经有13人回复
-
药理学论文润色/翻译怎么收费?
已经有175人回复
-
2026年山东大学海洋学院生物与医药博士招生-李霞课题组
已经有0人回复
-
博士研究生招生
已经有0人回复
-
碱缸的配制
已经有5人回复
-
新！澳门科技大学诚招2026年秋季药剂学/生物材料方向博士研究生（申请-考核制）
已经有18人回复
-
澳科大药学院诚招2026年秋季纳米医学/生物材料博士研究生
已经有16人回复
-
医药口服制剂辅料应用
已经有0人回复
-
全新推出Tguide®靶向递送方案，突破99% T细胞转染效率
已经有1人回复
llb1978
金虫 (正式写手)
- 应助: 2 (幼儿园)
- 金币: 1364.2
- 红花: 2
- 帖子: 462
- 在线: 24.7小时
- 虫号: 92998
- 注册: 2005-09-12
- 性别: GG
- 专业: 药物学
★
李金平(金币+1):谢谢参与
李金平(金币+1):谢谢参与
|
http://www.ich.org/cache/compo/276-254-1.html Stability Q1A(R2) Stability Testing of New Drug Substances and Products Q1B Stability Testing : Photostability Testing of New Drug Substances and Products Q1C Stability Testing for New Dosage Forms Q1D Bracketing and Matrixing Designs for Stability Testing of New Drug Substances and Products Q1E Evaluation of Stability Data Q1F Stability Data Package for Registration Applications in Climatic Zones III and IV Analytical Validation Q2(R1) New title: Validation of Analytical Procedures: Text and Methodology Previously: Text on Validation of Analytical Procedures Q2A Validation of Analytical Procedures: Methodology (in Q2(R1)) Q2B Impurities Q3A(R2) Impurities in New Drug Substances Q3A(R) Q3B(R2) Impurities in New Drug Products Q3B(R) Q3C(R4) Impurities: Guideline for Residual Solvents Q3C Impurities: Guideline for Residual Solvents (Maintenance) PDE for Tetrahydrofuran (in Q3C(R3)) Q3C(M) PDE for N-Methylpyrrolidone (in Q3C(R3)) Q3C(M) Procedures are described here Pharmacopoeias Q4 Pharmacopoeias Q4A Pharmacopoeial Harmonisation Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions Q4B Annex 1 Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Residue on Ignition/Sulphated Ash General Chapter Q4B Annex 2 Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Test for Extractable Volume of Parenteral Preparations General Chapter Q4B Annex 3 Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Test for Particulate Contamination: Sub-Visible Particles General Chapter Q4B Annex 4A Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Microbiological Examination of Non-Sterile Products: Microbial Enumeration Tests General Chapter Q4B Annex 4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Microbiological Examination of Non-Sterile Products: Tests for Specified Micro-organisms General Chapter Q4B Annex 4C Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Microbiological Examination of Non-Sterile Products: Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use General Chapter Q4B Annex 5 Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Disintegration Test General Chapter Q4B Annex 6 Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Uniformity of Dosage Units General Chapter Q4B Annex 7 Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Dissolution Test General Chapter Q4B Annex 8 Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Test for Sterility General Chapter Q4B Annex 9 Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Tablet Friability General Chapter Q4B Annex 10 Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions on Polyacramyde Gel Electrophoresis General Chapter Quality of Biotechnological Products Q5A(R1) Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin Q5A Q5B Quality of Biotechnological Products : Analysis of the Expression Construct in Cells Used for Production of r-DNA Derived Protein Products Q5C Quality of Biotechnological Products : Stability Testing of Biotechnological/Biological Products Q5D Derivation and Characterisation of Cell Substrates Used for Production of Biotechnological/Biological Products Q5E Comparability of Biotechnological/Biological Products Subject to Changes in their Manufacturing Process Specifications Q6A Specifications : Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances (including Decision Trees) Q6B Specifications : Test Procedures and Acceptance Criteria for Biotechnological/Biological Products Good Manufacturing Practice Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients Q7A Pharmaceutical Development Q8(R1) Pharmaceutical Development Quality Risk Management Q9 Quality Risk Management Pharmaceutical Quality System Q10 Pharmaceutical Quality System Q8/9/10 Q&As Q8/Q9/Q10 - Questions & Answers document |
3楼2009-07-24 07:23:59
  |
14楼2009-07-27 22:12:22